Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01625871
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:23.597103+00:00
Published At
2013-01-17T00:00:00+00:00
Record Updated At
2013-01-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Vivax Malaria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-01-17"
protocolSection.identificationModule.nctId
"NCT01625871"
protocolSection.identificationModule.officialTitle
"Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Vivax Malaria (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.